Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 25th Oct 2021 16:03

Tuesday 26 October 
Dispersion Holdings PLCGM re share allotment
Wednesday 27 October 
Cap-XX LtdAGM
Frontier Developments PLCAGM
Hargreaves Services PLCAGM
Ideagen PLCAGM
Investment Co PLCAGM
Invinity Energy Systems PLCAGM
JPMorgan Global Growth & Income PLCAGM
Mirada PLCAGM
Pantheon International PLCAGM
Puma VCT 11 PLCGM re winding up
Springfield Properties PLCAGM
Thursday 28 October 
Brooks Macdonald Group PLCAGM
City of London Investment Trust PLCAGM
Filtronic PLCAGM
Highbridge Tactical Credit Fund LtdAGM
JD Sports Fashion PLCGM re proposed share sub-division
National Milk Records PLCAGM
South32 LtdAGM
Tirupati Graphite PLCAGM
Tirupati Graphite PLCGM re acquisition, warrants
Friday 29 October 
ADM Energy PLCAGM
Adriatic Metals PLCGM re funding package for Vares silver project
ITM Power PLCAGM
Mattioli Woods PLCAGM
MaxCyte PLCAGM
OPG Power Ventures PLCAGM
Sensyne Health PLCAGM
Monday 1 November 
Capital & Regional PLCGM re capital raising
Electra Private Equity PLCGM re Hostmore demerger
French Connection Group PLCGM re takeover by MIP Holdings
Silence Therapeutics PLCGM re cancellation of admission to trading
Vietnam Holding LtdAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Nov 2021 12:59

IN BRIEF: Silence Therapeutics to delist from AIM next week

IN BRIEF: Silence Therapeutics to delist from AIM next week

Read more
26 Nov 2021 09:53

Silence Therapeutics to proceed with AIM delisting next week

(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced on 15 October.

Read more
16 Nov 2021 12:23

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

Read more
16 Nov 2021 11:39

Revenue, expenses rise in third quarter for Silence Therapeutics

(Sharecast News) - Silence Therapeutics said on Tuesday that its revenue increased by £1.2m year-on-year in its third quarter, as a result of the further advancement of its partner programmes, as well as the introduction of additional programmes with its partners.

Read more
5 Nov 2021 18:40

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

Read more
5 Nov 2021 11:39

Frazier Life Sciences becomes 'important' new Silence Therapeutics shareholder

(Sharecast News) - Novel short interfering ribonucleic acid (siRNA) therapy developer Silence Therapeutics announced on Friday that healthcare-focussed investor Frazier Life Sciences Public Fund had purchased about $20m of its existing shares.

Read more
22 Oct 2021 20:26

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

Read more
15 Oct 2021 15:40

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh

Read more
15 Oct 2021 14:15

IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh

IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh

Read more
15 Oct 2021 12:23

Silence Therapeutics inks collaboration deal with Hansoh Pharmaceutical

(Sharecast News) - Silence Therapeutics announced a collaboration with Hansoh Pharmaceutical Group on Friday, to develop short interfering ribonucleic acids (siRNAs) for three undisclosed targets, leveraging its proprietary 'mRNAi GOLD' platform.

Read more
1 Sep 2021 09:30

Silence promotes John Strafford to head new product development

(Sharecast News) - Silence Therapeutics announced the appointment of John Strafford to the newly-created role of senior vice-president of business development, alliance management and new product development on Wednesday, effective immediately.

Read more
12 Aug 2021 13:56

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

Read more
12 Aug 2021 09:37

Silence Therapeutics losses widen as it progresses programmes

(Sharecast News) - Silence Therapeutics reported revenues from collaborations of £5.8m in its first half on Thursday, up from £1.1m year-on-year, which it put down to its work with AstraZeneca and Mallinckrodt.

Read more
5 Aug 2021 16:18

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.